• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Liraglutide suppresses the proliferation of endometrial cancer cells through the adenosine 5'-monophosphate (AMP)-activated protein kinase signaling pathway.

作者信息

Zhu Xin-Xin, Feng Zong-Hao, Liu Lin-Zhi, Zhang Yan

机构信息

Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China.

Department of Obstetrics and Gynecology, Beijing Tsinghua Changgung Hospital, Beijing 102218, China.

出版信息

Chin Med J (Engl). 2021 Jan 19;134(5):576-578. doi: 10.1097/CM9.0000000000001363.

DOI:10.1097/CM9.0000000000001363
PMID:33470656
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7929608/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f939/7929608/70b7ab63a332/cm9-134-576-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f939/7929608/70b7ab63a332/cm9-134-576-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f939/7929608/70b7ab63a332/cm9-134-576-g001.jpg

相似文献

1
Liraglutide suppresses the proliferation of endometrial cancer cells through the adenosine 5'-monophosphate (AMP)-activated protein kinase signaling pathway.利拉鲁肽通过5'-单磷酸腺苷（AMP）激活的蛋白激酶信号通路抑制子宫内膜癌细胞的增殖。
Chin Med J (Engl). 2021 Jan 19;134(5):576-578. doi: 10.1097/CM9.0000000000001363.
2
Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice.利拉鲁肽是一种胰高血糖素样肽-1（GLP-1）受体激动剂，它通过增强AMP激活的蛋白激酶和细胞周期调节来抑制血管平滑肌细胞增殖，并延缓载脂蛋白E缺乏小鼠的动脉粥样硬化进程。
Atherosclerosis. 2017 Jun;261:44-51. doi: 10.1016/j.atherosclerosis.2017.04.001. Epub 2017 Apr 7.
3
Liraglutide Inhibits Hepatitis C Virus Replication Through an AMP Activated Protein Kinase Dependent Mechanism.利拉鲁肽通过 AMP 激活的蛋白激酶依赖机制抑制丙型肝炎病毒复制。
Int J Mol Sci. 2019 Sep 14;20(18):4569. doi: 10.3390/ijms20184569.
4
Effects of metformin on endometrial cancer cell growth in vivo: a preoperative prospective trial.二甲双胍对子宫内膜癌细胞生长的体内影响：一项术前前瞻性试验。
Cancer. 2014 Oct 1;120(19):2986-95. doi: 10.1002/cncr.28853. Epub 2014 Jun 10.
5
Interaction of renin-angiotensin system and adenosine monophosphate-activated protein kinase signaling pathway in renal carcinogenesis of uninephrectomized rats.肾切除大鼠肾癌发生过程中肾素-血管紧张素系统与腺苷酸活化蛋白激酶信号通路的相互作用
Tumour Biol. 2017 May;39(5):1010428317699116. doi: 10.1177/1010428317699116.
6
Liraglutide enhances glucose transporter 4 translocation via regulation of AMP-activated protein kinase signaling pathways in mouse skeletal muscle cells.利拉鲁肽通过调节 AMP 激活的蛋白激酶信号通路增强小鼠骨骼肌细胞葡萄糖转运蛋白 4 的转位。
Metabolism. 2014 Aug;63(8):1022-30. doi: 10.1016/j.metabol.2014.05.008. Epub 2014 May 17.
7
Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.二甲双胍通过βKlotho相关的ERK1/2信号通路和AMPKα信号通路抑制17β-雌二醇诱导的子宫内膜腺癌细胞上皮-间质转化。
Oncotarget. 2016 Apr 19;7(16):21315-31. doi: 10.18632/oncotarget.7040.
8
Curcumin Regulates the Progression of Colorectal Cancer via LncRNA NBR2/AMPK Pathway.姜黄素通过长链非编码 RNA NBR2/AMPK 通路调节结直肠癌的进展。
Technol Cancer Res Treat. 2019 Jan-Dec;18:1533033819870781. doi: 10.1177/1533033819870781.
9
The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway.人胰高血糖素样肽-1 类似物利拉鲁肽通过 AMPK/mTOR/P70S6K 信号通路调节胰岛β细胞增殖和凋亡。
Peptides. 2013 Jan;39:71-9. doi: 10.1016/j.peptides.2012.10.006. Epub 2012 Oct 30.
10
2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.2-芳基噻唑烷-4-羧酸酰胺（ATCAA）靶向癌细胞中的两条途径：5'-AMP 激活的蛋白激酶（AMPK）/mTOR 和 PI3K/Akt/mTOR 途径。
Int J Oncol. 2010 Oct;37(4):1023-30.

引用本文的文献

1
Glucagon-like peptide 1 receptor agonists and cancer risk: advancing precision medicine through mechanistic understanding and clinical evidence.胰高血糖素样肽1受体激动剂与癌症风险：通过机制理解和临床证据推动精准医学发展
Biomark Res. 2025 Mar 27;13(1):50. doi: 10.1186/s40364-025-00765-3.
2
Semaglutide, a glucagon-like peptide-1 receptor agonist, inhibits oral squamous cell carcinoma growth through P38 MAPK signaling pathway.司美格鲁肽是一种胰高血糖素样肽-1受体激动剂，通过P38丝裂原活化蛋白激酶信号通路抑制口腔鳞状细胞癌的生长。
J Cancer Res Clin Oncol. 2025 Mar 7;151(3):103. doi: 10.1007/s00432-025-06154-5.
3
Anti-Diabetic Therapies and Cancer: From Bench to Bedside.
抗糖尿病治疗与癌症：从基础到临床。
Biomolecules. 2024 Nov 20;14(11):1479. doi: 10.3390/biom14111479.
4
The Potential Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists as a Type of Conservative Treatment of Endometrial Cancer in Women of Reproductive Age: A Review of the Literature and a Call for Study.胰高血糖素样肽-1（GLP-1）受体激动剂作为一种对育龄期女性子宫内膜癌保守治疗方法的潜在作用：文献综述与研究呼吁
Cureus. 2024 Sep 18;16(9):e69678. doi: 10.7759/cureus.69678. eCollection 2024 Sep.
5
Glucagon-like peptide-1 analogs activate AMP kinase leading to reversal of the Warburg metabolic switch in breast cancer cells.胰高血糖素样肽-1 类似物激活 AMP 激酶，导致乳腺癌细胞中沃伯格代谢开关的逆转。
Med Oncol. 2024 May 6;41(6):138. doi: 10.1007/s12032-024-02390-w.
6
Modulatory effect of liraglutide on doxorubicin-induced testicular toxicity and behavioral abnormalities in rats: role of testicular-brain axis.利拉鲁肽对多柔比星诱导的大鼠睾丸毒性和行为异常的调节作用：睾丸-脑轴的作用。
Naunyn Schmiedebergs Arch Pharmacol. 2023 Nov;396(11):2987-3005. doi: 10.1007/s00210-023-02504-7. Epub 2023 May 10.
7
Clinical Impact of Glucagon-Like Peptide-1 Receptor Analogs on the Complications of Obesity.胰高血糖素样肽-1 受体激动剂对肥胖并发症的临床影响。
Obes Facts. 2023;16(2):149-163. doi: 10.1159/000526808. Epub 2022 Nov 8.
8
GLP1R inhibits the progression of endometrial carcinoma through activation of cAMP/PKA pathway.GLP1R 通过激活 cAMP/PKA 通路抑制子宫内膜癌的进展。
J Clin Lab Anal. 2022 Oct;36(10):e24604. doi: 10.1002/jcla.24604. Epub 2022 Aug 21.